(IN BRIEF) ING Group has initiated a €2.5 billion share buyback program to enhance its Common Equity Tier 1 (CET1) ratio. The move follows ING’s aim to converge its CET1 ratio toward a target of approximately 12.5%, as announced earlier … Read the full press release
Posted in Banks, Financial, Investment, Netherlands
Tagged CET1 ratio, ECB, ING, ING Groep N.V., Market Abuse Regulation, share buyback programme, shares
(ACTUALITÉ EN BREF) ING a annoncé un programme de rachat d’actions, en vertu duquel elle prévoit de racheter des actions ordinaires d’ING Groep N.V. pour un montant maximum de 50 millions d’euros afin de respecter les obligations découlant des plans … Read the full press release
(IN BRIEF) ING has announced a share repurchase programme, under which it plans to repurchase ordinary shares of ING Groep N.V. for up to €50 million to meet obligations under share-based compensation plans. The programme is expected to start on … Read the full press release
Posted in Banks, Financial, Investment, Netherlands
Tagged buyback programme, compensation plans, ECB, ING, ING Groep N.V., ordinary shares, share repurchase, Share Repurchase Programme
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
